Development of a Risk Predictive Model for Evaluating Immune Infiltration Status in Invasive Thyroid Carcinoma

Figure 6

External validation for the model. (a) Sparse hierarchical clustering for all tumor samples in GSE35570 (left) and GSE65074 (right); heatmap shows the expression pattern of 29 immune-related genes sets between immune-activated and immunosuppressive groups in GSE35570 (b) and GSE65074 (c) datasets; (d) ROC curve shows the predictive performance of risk-score model in GSE35570 (left) and GSE65074 (right) dataset; genes in model differentially expressed between immune-activated and immunosuppressive groups in GSE35570 (e) and GSE65074 (f) datasets; decision curve analysis and clinical impact curve show the clinical benefits and accuracy of the model based on GSE35570 (g) and GSE65074 (h) datasets.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)